CN106489847A - 一种能分泌降血压蜂毒的蚂蜂饲养方法 - Google Patents
一种能分泌降血压蜂毒的蚂蜂饲养方法 Download PDFInfo
- Publication number
- CN106489847A CN106489847A CN201610926073.2A CN201610926073A CN106489847A CN 106489847 A CN106489847 A CN 106489847A CN 201610926073 A CN201610926073 A CN 201610926073A CN 106489847 A CN106489847 A CN 106489847A
- Authority
- CN
- China
- Prior art keywords
- hornet
- parts
- bee venom
- hypotensive
- breeding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003659 bee venom Substances 0.000 title claims abstract description 62
- 241000256856 Vespidae Species 0.000 title claims abstract description 60
- 238000000034 method Methods 0.000 title claims abstract description 29
- 230000001077 hypotensive effect Effects 0.000 title claims abstract description 20
- 238000009395 breeding Methods 0.000 title claims abstract description 19
- 230000001488 breeding effect Effects 0.000 title claims abstract description 19
- 208000001953 Hypotension Diseases 0.000 title claims abstract description 17
- 208000021822 hypotensive Diseases 0.000 title claims abstract description 17
- 210000004072 lung Anatomy 0.000 claims abstract description 20
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011777 magnesium Substances 0.000 claims abstract description 17
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 16
- 241001113925 Buddleja Species 0.000 claims abstract description 15
- 241000756943 Codonopsis Species 0.000 claims abstract description 15
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 14
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 14
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 13
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 13
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 11
- 230000013011 mating Effects 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 241000256844 Apis mellifera Species 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000002023 wood Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 239000006286 aqueous extract Substances 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 239000002435 venom Substances 0.000 claims description 5
- 231100000611 venom Toxicity 0.000 claims description 5
- 210000001048 venom Anatomy 0.000 claims description 5
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 240000007171 Imperata cylindrica Species 0.000 claims 2
- 244000018633 Prunus armeniaca Species 0.000 claims 1
- 235000009827 Prunus armeniaca Nutrition 0.000 claims 1
- 230000028327 secretion Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 description 11
- 241001598107 Imperata Species 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 108010036176 Melitten Proteins 0.000 description 3
- 101710096328 Phospholipase A2 Proteins 0.000 description 3
- 102100026918 Phospholipase A2 Human genes 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- LQHZJYFIRFRDKF-UHFFFAOYSA-N gold magnesium Chemical compound [Mg].[Au] LQHZJYFIRFRDKF-UHFFFAOYSA-N 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 108010077372 mast cell degranulating peptide Proteins 0.000 description 3
- QMBRLNFAEHGOLY-UHFFFAOYSA-N mcd peptide Chemical compound N1C(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)C(C)CC)CSSCC(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC(N)=O)C(N)=O)NC(=O)C(C(C)CC)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(C(C)CC)NC(=O)C(CC2N=CN=C2)NC(=O)C2CCCN2C(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC2=O)CSSCC1C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC2CC1C=NC=N1 QMBRLNFAEHGOLY-UHFFFAOYSA-N 0.000 description 3
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 2
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- PZEUTLIKVUEDLB-UHFFFAOYSA-N 2-[[[2-[[6-amino-2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoylamino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(carbamoylamino)propanoyl]-(3-amino-3-oxopropyl)carbamoyl]amino]pentanediamide Chemical compound CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CNC(N)=O)C(=O)N(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O PZEUTLIKVUEDLB-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 1
- DLHXRDUXNVEIEY-UHFFFAOYSA-N 7-Methylcoumarin Chemical class C1=CC(=O)OC2=CC(C)=CC=C21 DLHXRDUXNVEIEY-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- -1 Acyl glycerol Chemical compound 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000243818 Annelida Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- PVKQULHHWVQXLE-UHFFFAOYSA-N Glycyrol Natural products C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(O)=C(CC=C(C)C)C(OC)=C1 PVKQULHHWVQXLE-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 241000594394 Hedyotis Species 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- 241000545744 Hirudinea Species 0.000 description 1
- 240000008375 Hymenaea courbaril Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010010164 Hypertension complications Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 241000500891 Insecta Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- GFJNBLOMWYSKSS-UHFFFAOYSA-N Isoglycyrol Natural products COc1c2CCC(C)(C)Oc2cc3OC(=O)c4c(oc5c(O)cccc45)c13 GFJNBLOMWYSKSS-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- MVAUGMLUJKTORM-UHFFFAOYSA-N Licoricidin Natural products COc1cc2OCC(Cc2cc1CC=C(C)C)c3ccc(O)c(CC=C(C)C)c3O MVAUGMLUJKTORM-UHFFFAOYSA-N 0.000 description 1
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000346285 Ostrinia furnacalis Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- PEFASEPMJYRQBW-HKWQTAEVSA-N Robinin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-HKWQTAEVSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000256011 Sphingidae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- QBYFCXBVWQQXFH-UHFFFAOYSA-N acaciin Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4OC6OCC(O)C(O)C6O)cc3O2 QBYFCXBVWQQXFH-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 229940001501 fibrinolysin Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- LWESBHWAOZORCQ-UHFFFAOYSA-N glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CC=C(C)C)C(O)=C1 LWESBHWAOZORCQ-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000266 injurious effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- CFWLRXJPRRCJTI-UHFFFAOYSA-N iso-glycyrol Chemical compound C12=CC=C(O)C=C2OC2=C1C(=O)OC1=C2C(OC)=C(CCC(C)(C)O2)C2=C1 CFWLRXJPRRCJTI-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- DDELFAUOHDSZJL-UHFFFAOYSA-N kaempferol 3-O-rutinoside-7-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C1=O DDELFAUOHDSZJL-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-UHFFFAOYSA-N kaempferol 7-O-alpha-L-rhamnopyradoside 3-O-beta-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-UHFFFAOYSA-N 0.000 description 1
- GBRZTUJCDFSIHM-KRWDZBQOSA-N licoricidin Chemical compound C1([C@@H]2COC=3C=C(O)C(CC=C(C)C)=C(C=3C2)OC)=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-KRWDZBQOSA-N 0.000 description 1
- GBRZTUJCDFSIHM-UHFFFAOYSA-N licorisoflavan B Natural products C1C=2C(OC)=C(CC=C(C)C)C(O)=CC=2OCC1C1=CC=C(O)C(CC=C(C)C)=C1O GBRZTUJCDFSIHM-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010070324 lumbrokinase Proteins 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- PEFASEPMJYRQBW-XMWKPCQISA-N robinin Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O4)c3)C2=O)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 PEFASEPMJYRQBW-XMWKPCQISA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Classifications
-
- A01K67/033—
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及养殖技术领域，尤其是涉及一种能分泌降血压蜂毒的蚂蜂饲养方法。将野外采集的蚂蜂，经人工喂养、交尾、分巢建群后进行养殖，其特征在于：将蜂群置于养殖大棚中，在大棚中每隔10米距离地面3‑8米设置一个蜂巢箱，同时提供充足的饲料、筑巢材料供蚂蜂采用；大棚控温20‑30℃，空气相对湿度为40‑60％；定期对蚂蜂采集蜂毒；所述饲料按重量份计由以下原料组成：花粉1‑2份，蟋蟀10‑15份、猪肺5‑10份、地龙4‑8份、蜂蜜3‑8份、富镁金银花1‑2份、党参0.5‑1份、银杏叶1‑2份、茯苓0.5‑1份、密蒙花0.5‑1份。本发明饲养蚂蜂分泌蜂毒具有更佳降血压作用。
Description
【技术领域】
本发明涉及养殖技术领域，尤其是涉及一种能分泌降血压蜂毒的蚂蜂饲养方法。
【背景技术】
蚂蜂别名胡蜂，属于昆虫纲，膜翅目，胡蜂科昆虫，是一类具有丰富的开发利用价值的昆虫类群，在生物防治方面，蚂蜂为肉食性昆虫，具有食性广泛，捕食迅速的特点，可以捕食棉铃虫、玉米螟、天蛾等多种农林害虫的幼虫，可作为天敌用于生物防治。蜂毒是工蜂毒腺和副腺分泌出的具有芳香气味的一种透明液体，贮存在毒囊中，针刺时由蛰针排出。蜂毒含有多种酶类、脂类、多肽类等物质，作用于人体的神经、心血管、内分泌及免疫等系统，能抗炎、镇痛、改善微循环、促进机体新陈代谢、调节免疫力和抗病能力。
据研究蜂毒具有明显的降压作用，能适应治疗高血压要降压的需求，蜂毒在降低动脉压的同时，具有扩张血管的能力，使脑血容量增加。蜂毒中富含蜂毒肽、PLA2、MCD-肽等成分，能有效促进组织胺的释放，从而能使血管扩张降低血压。蜂毒中含有镁、铜、钾等微等微量元素，还有维生素和酶类等天然的抗氧化剂，可以有效地清除人体内过剩的自由基，阻断脂质过氧化，不仅减少过氧化脂质对血管的危害，阻止血管硬化，而且还能有效地降低三酰甘油含量，减少血小板聚集，改善微循环，防止高血压合并症的发生。而蜂毒疗法作为一种自然疗法,不仅具有独特的临床疗效,副作用也很小,应用前景广阔，如何进一步提高蜂毒降压效果是人们所期待的。
【发明内容】
鉴于以上内容，有必要提供一种蚂蜂的饲养方法，使得蚂蜂所分泌蜂毒有更好的降压效果。
本发明的目的通过以下技术方案实现：
一种能分泌降血压蜂毒的蚂蜂饲养方法，将野外采集的蚂蜂，经人工喂养、交尾、分巢建群后进行养殖，将蜂群置于养殖大棚中，在大棚中每隔10米距离地面3-8米设置一个蜂巢箱，同时提供充足的饲料、筑巢材料供蚂蜂采用；大棚控温20-30℃，空气相对湿度为40-60％；定期对蚂蜂采集蜂毒；所述饲料按重量份计由以下原料组成：花粉1-2份，蟋蟀10-15份、猪肺5-10份、蜂蜜4-15份、地龙4-8份、富镁金银花1-2份、党参0.5-1份、银杏叶1-2份、茯苓0.5-1份、密蒙花0.5-1份。
进一步所述饲料制备方法为：取富镁金银花、党参、银杏叶、茯苓及密蒙花加入5倍重量的水制成水提液，过滤去除沉淀滤渣，将滤液置于800mmHg真空度下浓缩至滤液体积的20％得到浓缩液，将浓缩液与花粉、蟋蟀、猪肺、地龙和蜂蜜混合均匀即可得到饲料。
进一步的，所述蟋蟀和猪肺为新鲜蟋蟀和猪肺粉碎物。
进一步的，所述采集蜂毒采用电取蜂毒法，取蜂毒时对采毒蚂蜂施加30伏的电压持续刺激15秒，停电时间为10秒再次通电，循环3-5次。
进一步的，所述定期对蚂蜂采集蜂毒是指间隔8-12天取一次蜂毒。
进一步的，所述筑巢材料为朽木树皮、秸秆、干树叶、茅草的混合物。
进一步的，所述朽木树皮、秸秆、干树叶、茅草在作为筑巢材料使用时，切割为长0.5cm、宽0.5cm大小。
甘草：别名国老、甜草、乌拉尔甘草、甜根子。豆科、甘草属多年生草本，根与根状茎粗壮，是一种补益中草药，用于用于心气虚，心悸怔忡，脉结代，以及脾胃气虚，倦怠乏力等，甘草含有多种化学成分，主要成分有甘草酸、甘草甙等。甘草的化学组成极为复杂，目前为止从甘草中分离出的化合物有甘草甜素、甘草次酸、甘草甙、异甘草甙、新甘草甙、新异甘草甙、甘草素、异甘草素以及甘草西定、甘草醇、异甘草醇、7-甲基香豆精、伞形花内酯等数十种化合物，但这些成分和数量通常会随甘草的种类、种植区域、采收时间等因素的不同而异。大量的研究表明，甘草甜素和黄酮类物质是甘草中最重要的生理活性物质，主要存在于甘草根表皮以内的部分。
银杏叶：银杏叶提取物不仅具有敛肺、平喘、活血化瘀、止痛、促进血液循环、预防心血管病、改善脑功能和末梢循环障碍等功能，还具有很强的清除自由基和抗氧化的作用。常用于瘀血阻络，胸痹心痛，中风偏瘫，肺虚咳喘，高脂血症。
地龙：为环节动物门钜蚓科动物参环毛蚓干燥体，含有胶原酶、纤溶酶、蚓激酶、核酸、微量元素等多种成分，被广泛用于药物中，主治清热定惊，通络，平喘，利尿。用于高热神昏，惊痫抽搐，关节痹痛，肢体麻木，半身不遂，肺热咳喘。
富镁金银花：性寒，味甘，入肺、心、胃经，具有清热解毒、抗炎、补虚疗风的功效。金银花中所含的绿原酸能引起中枢神经兴奋，其作用强度为咖啡因的1/6，有抗疲劳的功效。镁是维持人体生命活动的必需元素，具有调节神经和肌肉活动、增强耐久力的神奇功能。此外，镁也是高血压、高胆固醇、高血糖的“克星”，它还有助于防治中风、冠心病和糖尿病。镁有助于调节人的心脏活动，降低血压，预防心脏病，提高男士的生育能力。
党参具有补中益气，健脾益肺之功效。党参有增强免疫力、扩张血管、降压、改善微循环、增强造血功能等作用
茯苓：为多孔菌科真菌茯苓的干燥菌核，主要具有利水渗湿的功效，广泛用于水湿内停所致的水肿、痰饮、泄泻、小便不畅等多种病证。
密蒙花：味甘，性微寒，归肝经，具有清热养肝、明目退翳的功效。现代研究证实，密蒙花含刺槐素、刺槐甙等，其中刺槐素有维生素P样作用，可降低血管通透性及脆性，并有一定的抗炎及解痉作用，广西的壮族人每年农历三月三或清明节，家家户户蒸五色糯米饭。其中香饽饽的黄色糯米饭就是用密蒙花染制的。
本发明有益效果：
1.使用本发明饲养蚂蜂方法所产蜂毒相比普通蚂蜂所产蜂毒对于降血压具有更显著效果，本发明在蚂蜂饲料中添加地龙、富镁金银花、党参、银杏叶、茯苓及密蒙花中草药成分，在蚂蜂生物酶作用下分解酿制，经过蚂蜂体内生物物理转化，使得蚂蜂所产蜂毒具有更丰富的蜂毒肽、PLA2、MCD-肽；同时比普通蜂毒含有更多的镁、铜、钾等微量元素，还有更高的维生素、酶类等天然的抗氧化剂。上述中草药相互配合增效，使得蚂蜂所产蜂毒有更好的降血压作用。
2.本发明饲养蚂蜂管理方法科学，利于蚂蜂的生长及分泌蜂毒，具有很好的经济效益。
【具体实施方式】
实施例1
一种能分泌降血压蜂毒的蚂蜂饲养方法，将野外采集的蚂蜂，经人工喂养、交尾、分巢建群后进行养殖，将蜂群置于养殖大棚中，在大棚中每隔10米距离地面3米设置一个蜂巢箱，同时提供充足的饲料、筑巢材料供蚂蜂采用；大棚控温20℃，空气相对湿度为40％；定期对蚂蜂采集蜂毒；所述饲料按重量份计由以下原料组成：花粉1份，蟋蟀10份、猪肺5份、蜂蜜4份、地龙4份、富镁金银花1份、党参0.5份、银杏叶1份、茯苓0.5份、密蒙花0.5份。富镁金银花、党参、银杏叶、茯苓及密蒙花加入5倍重量的水制成水提液，过滤去除沉淀滤渣，将滤液置于800mmHg真空度下浓缩至滤液体积的20％得到浓缩液，将浓缩液与花粉、蟋蟀、猪肺、地龙和蜂蜜混合均匀即可得到饲料。所述定期对蚂蜂采集蜂毒是指间隔8天取一次蜂毒。所述采集蜂毒采用电取蜂毒法，取蜂毒时对采毒蚂蜂施加30伏的电压持续刺激15秒，停电时间为10秒再次通电，循环3次。所述筑巢材料为将朽木树皮、秸秆、干树叶、茅草切割为长0.5cm、宽0.5cm大小的混合物。
实施例2
一种能分泌降血压蜂毒的蚂蜂饲养方法，将野外采集的蚂蜂，经人工喂养、交尾、分巢建群后进行养殖，将蜂群置于养殖大棚中，在大棚中每隔10米距离地面8米设置一个蜂巢箱，同时提供充足的饲料、筑巢材料供蚂蜂采用；大棚控温30℃，空气相对湿度为60％；定期对蚂蜂采集蜂毒；所述饲料按重量份计由以下原料组成：花粉2份，蟋蟀15份、猪肺10份、蜂蜜15份、地龙8份、富镁金银花2份、党参1份、银杏叶2份、茯苓1份、密蒙花1份。富镁金银花、党参、银杏叶、茯苓及密蒙花加入5倍重量的水制成水提液，过滤去除沉淀滤渣，将滤液置于800mmHg真空度下浓缩至滤液体积的20％得到浓缩液，将浓缩液与花粉、蟋蟀、猪肺、地龙和蜂蜜混合均匀即可得到饲料。所述定期对蚂蜂采集蜂毒是指间隔12天取一次蜂毒。所述采集蜂毒采用电取蜂毒法，取蜂毒时对采毒蚂蜂施加30伏的电压持续刺激15秒，停电时间为10秒再次通电，循环3-5次。所述筑巢材料为将朽木树皮、秸秆、干树叶、茅草切割为长0.5cm、宽0.5cm大小的混合物。
实施例3
一种能分泌降血压蜂毒的蚂蜂饲养方法，将野外采集的蚂蜂，经人工喂养、交尾、分巢建群后进行养殖，将蜂群置于养殖大棚中，在大棚中每隔10米距离地面3-8米设置一个蜂巢箱，同时提供充足的饲料、筑巢材料供蚂蜂采用；大棚控温25℃，空气相对湿度为40-60％；定期对蚂蜂采集蜂毒；所述饲料按重量份计由以下原料组成：花粉1.5份，蟋蟀13份、猪肺8份、蜂蜜8份、地龙6份、富镁金银花2份、党参1份、银杏叶1.5份、茯苓0.8份、密蒙花0.8份。富镁金银花、党参、银杏叶、茯苓及密蒙花加入5倍重量的水制成水提液，过滤去除沉淀滤渣，将滤液置于800mmHg真空度下浓缩至滤液体积的20％得到浓缩液，将浓缩液与花粉、蟋蟀、猪肺、地龙和蜂蜜混合均匀即可得到饲料。所述定期对蚂蜂采集蜂毒是指间隔10天取一次蜂毒。所述采集蜂毒采用电取蜂毒法，取蜂毒时对采毒蚂蜂施加30伏的电压持续刺激15秒，停电时间为10秒再次通电，循环4次。所述筑巢材料为将朽木树皮、秸秆、干树叶、茅草切割为长0.5cm、宽0.5cm大小的混合物。
为验证本发明能分泌降血压蜂毒的蚂蜂饲养方法的效果，采用以下不同方式进行养殖蚂蜂，随机将蚂蜂平均分为两群，置于同一区域进行养殖，实验组采用本发明实施例3饲养方法进行；对照组采用实施例3饲养方法进行喂养，但是饲料中不添加地龙、富镁金银花、党参、银杏叶、茯苓及密蒙花中草药成分，其他营养成分饲养管理方法相同。经测量实验组蜂毒中蜂毒肽、PLA2、MCD-肽含量比对照组高18.3％；镁、铜、钾等微量元素比对照组高27.6％。蜂毒中将血压有效成分的增加从而达到更佳的降血压效果。
Claims (7)
1.一种能分泌降血压蜂毒的蚂蜂饲养方法，将野外采集的蚂蜂，经人工喂养、交尾、分巢建群后进行养殖，其特征在于：将蜂群置于养殖大棚中，在大棚中每隔10米距离地面3-8米设置一个蜂巢箱，同时提供充足的饲料、筑巢材料供蚂蜂采用；大棚控温20-30℃，空气相对湿度为40-60％；定期对蚂蜂采集蜂毒；所述饲料按重量份计由以下原料组成：花粉1-2份，蟋蟀10-15份、猪肺5-10份、蜂蜜4-15份、地龙4-8份、富镁金银花1-2份、党参0.5-1份、银杏叶1-2份、茯苓0.5-1份、密蒙花0.5-1份。
2.根据权利要求1所述能分泌降血压蜂毒的蚂蜂饲养方法，其特征在于，所述饲料制备方法为：取富镁金银花、党参、银杏叶、茯苓及密蒙花加入5倍重量的水制成水提液，过滤去除沉淀滤渣，将滤液置于800mmHg真空度下浓缩至滤液体积的20％得到浓缩液，将浓缩液与花粉、蟋蟀、猪肺、地龙和蜂蜜混合均匀即可得到饲料。
3.根据权利要求1所述能分泌降血压蜂毒的蚂蜂饲养方法，其特征在于：所述蟋蟀和猪肺为新鲜蟋蟀和猪肺粉碎物。
4.根据权利要求1所述能分泌降血压蜂毒的蚂蜂饲养方法，其特征在于：所述采集蜂毒采用电取蜂毒法，取蜂毒时对采毒蚂蜂施加30伏的电压持续刺激15秒，停电时间为10秒再次通电，循环3-5次。
5.根据权利要求1所述能分泌降血压蜂毒的蚂蜂饲养方法，其特征在于：所述定期对蚂蜂采集蜂毒是指间隔8-12天取一次蜂毒。
6.根据权利要求1所述能分泌降血压蜂毒的蚂蜂饲养方法，其特征在于：所述筑巢材料为朽木树皮、秸秆、干树叶、茅草的混合物。
7.根据权利要求6所述能分泌降血压蜂毒的蚂蜂饲养方法，其特征在于：所述朽木树皮、秸秆、干树叶、茅草在作为筑巢材料使用时，切割为长0.5cm、宽0.5cm大小。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610926073.2A CN106489847A (zh) | 2016-10-31 | 2016-10-31 | 一种能分泌降血压蜂毒的蚂蜂饲养方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610926073.2A CN106489847A (zh) | 2016-10-31 | 2016-10-31 | 一种能分泌降血压蜂毒的蚂蜂饲养方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106489847A true CN106489847A (zh) | 2017-03-15 |
Family
ID=58319562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610926073.2A Pending CN106489847A (zh) | 2016-10-31 | 2016-10-31 | 一种能分泌降血压蜂毒的蚂蜂饲养方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106489847A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104067989A (zh) * | 2014-07-07 | 2014-10-01 | 唐金雷 | 胡蜂养殖方法 |
| CN104255668A (zh) * | 2014-09-24 | 2015-01-07 | 龙陵县黄氏蜂业有限公司 | 金环胡蜂繁育技术 |
| CN104756958A (zh) * | 2015-04-16 | 2015-07-08 | 广西容县梁丰养蜂专业合作社 | 一种防治蜜蜂病害的方法 |
| CN105878285A (zh) * | 2014-10-17 | 2016-08-24 | 北京久颐蜂科技有限公司 | 一种蜂毒精的制备方法 |
-
2016
- 2016-10-31 CN CN201610926073.2A patent/CN106489847A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104067989A (zh) * | 2014-07-07 | 2014-10-01 | 唐金雷 | 胡蜂养殖方法 |
| CN104255668A (zh) * | 2014-09-24 | 2015-01-07 | 龙陵县黄氏蜂业有限公司 | 金环胡蜂繁育技术 |
| CN105878285A (zh) * | 2014-10-17 | 2016-08-24 | 北京久颐蜂科技有限公司 | 一种蜂毒精的制备方法 |
| CN104756958A (zh) * | 2015-04-16 | 2015-07-08 | 广西容县梁丰养蜂专业合作社 | 一种防治蜜蜂病害的方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | Recent trends in potential traditional Indian herbs Emblica officinalis and its medicinal importance | |
| KR101483440B1 (ko) | 포제를 활용한 약용식물 추출물 및 이를 함유하는 피부외용제 조성물 | |
| KR101805004B1 (ko) | 약용 잎을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물 | |
| KR100475594B1 (ko) | 한방 및 천연추출물을 포함하는 미용팩용 화장료 조성물 제조방법 | |
| CN105076699A (zh) | 一种鲫鱼促长保健中草药添加剂 | |
| KR101162313B1 (ko) | 천연 생약제와 홍삼사포닌을 이용한 농사방법 | |
| Aja et al. | Comparative phytochemical composition of Cajanus cajan leaf and seed | |
| KR20190009884A (ko) | 굼벵이를 이용한 발효 건강식품 제조방법 | |
| CN106259071A (zh) | 一种河蟹的天然养殖方法 | |
| CN106489836A (zh) | 一种防治寄生虫的养猪法 | |
| AJA et al. | Ethno-entomological practices in Tirunelveli district, Tamil Nadu | |
| CN104904656A (zh) | 一种蛇的生态养殖方法 | |
| KR20180104516A (ko) | 건선, 아토피, 지루성피부염, 습진, 백반, 두드러기, 한포진, 여드름, 탈모, 모발손상, 두피염증, 비듬의 천연생약 치료 조성물 및 제조 방법 | |
| KR20140137155A (ko) | 원적외선수가 포함되는 발효 흑한방약재 제조방법 | |
| CN106489847A (zh) | 一种能分泌降血压蜂毒的蚂蜂饲养方法 | |
| KR101145498B1 (ko) | 천연한방추출물을 포함하는 바디워시제조방법 및 그 바디워시조성물 | |
| KR20110091959A (ko) | 암의 치료 개선효과를 갖는 무수 유산균발효 건강기능식품 조성물 및 그의 제조방법 | |
| CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
| KR20160147424A (ko) | 와송 추출물이 포함된 효소조성물 | |
| CN107960351A (zh) | 水蛭高产人工养殖方法 | |
| KR100537368B1 (ko) | 기능성 계란 산란용 사료, 그 식수, 이들을 급여하여 생산가능한 기능성 계란 및 그의 생산방법 | |
| EP3698643A1 (en) | The method of health maintaining and treating of the honey bee using herbal additives | |
| KR20110020691A (ko) | 발모촉진용 조성물 및 이의 제조방법 | |
| CN106359315A (zh) | 一种胡蜂养殖方法 | |
| KR100682046B1 (ko) | 루푸스 치료용 한약 추출물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170315 |
|
| RJ01 | Rejection of invention patent application after publication |